Showing results (3051-3060 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|March 21, 2025
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancerCharalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.Cancer Immunology, Immunotherapy : CII|October 9, 2024
Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysisYuelin Han, Xiangtian Xiao, Tingting Qin, et al.Cancer Immunology, Immunotherapy : CII|October 5, 2024
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 eraAllison L Gradone, Vincent T Ma, Alexi Vasbinder, et al.Cancer Immunology, Immunotherapy : CII|October 5, 2024
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft modelTetsuro Tachi, Noriyuki Kijima, Hideki Kuroda, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2024
Immunogenomic features of radiologically distinctive nodules in multiple primary lung cancerMei-Cheng Chen, Hao-Shuai Yang, Zhi Dong, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2024
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrenceYo Kawaguchi, Keigo Okamoto, Yoko Kataoka, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumorsRavit Geva, Maria Vieito, Jorge Ramon, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinomaWenjing Li, Jianqing You, Haixiang Xue, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case seriesRamya Muddasani, Neel Talwar, Isa Mambetsariev, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3Oscar Perales, Lucia Jilaveanu, Adebowale Adeniran, et al.Pageof 652